Genetic Signatures (ASX:GSS) Market Cap : A$127.74 Mil (As of Apr. 29, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Genetic Signatures's share price for the quarter that ended in Dec. 2023 was A$0.435. Genetic Signatures's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 164.92 Mil. Therefore, Genetic Signatures's market cap for the quarter that ended in Dec. 2023 was A$71.74 Mil.

Genetic Signatures's quarterly market cap declined from Dec. 2022 (A$126.20 Mil) to Jun. 2023 (A$75.29 Mil) and declined from Jun. 2023 (A$75.29 Mil) to Dec. 2023 (A$71.74 Mil).

Genetic Signatures's annual market cap increased from Jun. 2021 (A$157.20 Mil) to Jun. 2022 (A$166.33 Mil) but then declined from Jun. 2022 (A$166.33 Mil) to Jun. 2023 (A$75.29 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Genetic Signatures's Enterprise Value for Today is A$109.63 Mil.

Genetic Signatures Market Cap Historical Data

The historical data trend for Genetic Signatures's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures Market Cap Chart

Genetic Signatures Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Market Cap

Get a 7-Day Free Trial

140.45

306.61

157.20

166.33

75.29

Genetic Signatures Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Market Cap	Get a 7-Day Free Trial													256.14	166.33	126.20	75.29	71.74

Competitive Comparison of Genetic Signatures's Market Cap

For the Diagnostics & Research subindustry, Genetic Signatures's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Signatures's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's Market Cap distribution charts can be found below:

* The bar in red indicates where Genetic Signatures's Market Cap falls into.

Genetic Signatures Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Genetic Signatures's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as

Market Cap (A: Jun. 2023 )	=	Share Price (A: Jun. 2023 )	*	Shares Outstanding (EOP) (A: Jun. 2023 )
	=	A$0.512799	*	146.818
	=	A$75.29

Genetic Signatures's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	A$0.435	*	164.917
	=	A$71.74

Genetic Signatures (ASX:GSS) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Genetic Signatures Market Cap Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Signatures (ASX:GSS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042

Website

https://www.geneticsignatures.com

Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.